FAR North Queenslanders are being reminded to stay alert to symptoms of a dangerous seasonal disease, with cases of melioidosis taking a fatal toll. The Cairns and Hinterland Hospital and Health ...

The Harvard Pilgrim Health Care Institute is proud to announce the launch of the Center for Sepsis Epidemiology and ...

Immunocompromised participants were much more likely to have received at least four doses of COVID-19 vaccine than their ...

Pearl Diagnostics will receive $1 million to evaluate the potential of a prototype assay for early detection of pneumonia caused by Pseudomonas aeruginosa.

In an interview with The American Journal of Managed Care, Michael A. Bernstein, MD, stressed the need for effective ...

Photodynamic inactivation using curcumin shows promise in reducing antibiotic resistance diversity in Staphylococcus aureus, ...

By combining MERFISH imaging with expansion microscopy, researchers have unlocked a new way to study bacteria at the ...

An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

When managing an irritated cornea, choosing among fortified antibiotics, oral antivirals, anti-inflammatories or combination ...

The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...

Roorkee have uncovered a crucial regulatory mechanism in Acinetobacter baumannii -- a highly drug-resistant superbug ...